Europe Influenza Vaccines Market : Table of Contents

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Influenza Vaccines Market – By Vaccine Type

1.3.2 Europe Influenza Vaccines Market – By Virus Type

1.3.3 Europe Influenza Vaccines Market – By Technology

1.3.4 Europe Influenza Vaccines Market – By Route of Administration

1.3.5 Europe Influenza Vaccines Market – By Target Group

1.3.6 Europe Influenza Vaccines Market – By Country

2. Europe Influenza Vaccines Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Influenza Vaccines Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Europe PEST Analysis

4.3 Experts Opinion

5. Europe Influenza Vaccines Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Government Support to Promote Influenza Vaccination

5.1.2 Increasing Investment by Top Market Players and Governments

5.2 Market Restraints

5.2.1 High Cost of Vaccine Development

5.3 Market Opportunities

5.3.1 Emerging Economies

5.4 Future Trends

5.4.1 Strong Pipeline Candidates for Influenza Vaccines

5.5 Impact Analysis

6. Influenza Vaccine Market –Europe Analysis

6.1 Europe Influenza Vaccines Market, By Country - Forecasts And Analysis

6.2 Europe Influenza Vaccines Market Revenue Forecasts And Analysis

6.2.1 Europe: Influenza Vaccines Market, 2019–2028 (US$ Million)

7. Europe Influenza Vaccines Market Analysis and Forecasts To 2028 – By Vaccine Type

7.1 Overview

7.2 Europe Influenza Vaccines Market, By Vaccine Type 2022 & 2028 (%)

7.2.1 Europe: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)

7.3 Quadrivalent Vaccines

7.3.1 Overview

7.3.2 Quadrivalent Vaccines : Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

7.4 Trivalent Vaccines

7.4.1 Overview

7.4.2 Trivalent Vaccines : Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

8. Europe Influenza Vaccines Market Analysis and Forecasts To 2028 – By Virus Type

8.1 Overview

8.2 Europe Influenza Vaccines Market, By Virus Type 2022 & 2028 (%)

8.2.1 Europe: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)

8.3 Influenza Virus Type A

8.3.1 Overview

8.3.2 Influenza Virus Type A : Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Influenza Virus Type B

8.4.1 Overview

8.4.2 Influenza Virus Type B : Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

9. Europe Influenza Vaccines Market Analysis and Forecasts To 2028 – By Technology

9.1 Overview

9.2 Europe Influenza Vaccines Market, By Technology 2022 & 2028 (%)

9.2.1 Europe: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)

9.3 Egg-based

9.3.1 Overview

9.3.2 Egg-based : Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

9.4 Cell-based

9.4.1 Overview

9.4.2 Cell-Based : Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

10. Europe Influenza Vaccines Market Analysis and Forecasts To 2028 – By Route of Administration

10.1 Overview

10.2 Europe Influenza Vaccines Market, By Route of Administration 2022 & 2028 (%)

10.2.1 Europe: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)

10.2.2 Europe: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

10.3 Injection

10.3.1 Overview

10.3.2 Injection : Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

10.4 Nasal Spray

10.4.1 Overview

10.4.2 Nasal Spray: Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11. Europe Influenza Vaccines Market Analysis and Forecasts To 2028 – By Target Group

11.1 Overview

11.2 Europe Influenza Vaccines Market, By Target Group 2022 & 2028 (%)

11.2.1 Europe: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

11.3 Infants

11.3.1 Overview

11.3.2 Infants : Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11.4 Children

11.4.1 Overview

11.4.2 Children: Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11.5 Adults

11.5.1 Overview

11.5.2 Adults : Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11.6 Elderly People

11.6.1 Overview

11.6.2 Elderly People: Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

12. Europe Influenza Vaccines Market Analysis and Forecasts To 2028 – Country Analysis

12.1 Europe: Influenza Vaccines Market

12.1.1 Overview

12.1.2 Europe: Influenza Vaccines Market, by Country, 2022 & 2028 (%)

12.1.2.1 Germany: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.1.1 Overview

12.1.2.1.2 Germany: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.1.3 Germany: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)

12.1.2.1.4 Germany: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)

12.1.2.1.5 Germany: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)

12.1.2.1.6 Germany: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.2.1.7 Germany: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

12.1.2.2 UK: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.2.1 Overview

12.1.2.2.2 UK: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.2.3 UK: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)

12.1.2.2.4 UK: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)

12.1.2.2.5 UK: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)

12.1.2.2.6 UK: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.2.2.7 UK: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

12.1.2.3 France: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.3.1 Overview

12.1.2.3.2 France: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.3.3 France: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)

12.1.2.3.4 France: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)

12.1.2.3.5 France: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)

12.1.2.3.6 France: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.2.3.7 France: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

12.1.2.4 Italy: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.4.1 Overview

12.1.2.4.2 Italy: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.4.3 Italy: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)

12.1.2.4.4 Italy: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)

12.1.2.4.5 Italy: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)

12.1.2.4.6 Italy: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.2.4.7 Italy: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

12.1.2.5 Spain: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.5.1 Overview

12.1.2.5.2 Spain: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.5.3 Spain: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)

12.1.2.5.4 Spain: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)

12.1.2.5.5 Spain: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)

12.1.2.5.6 Spain: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.2.5.7 Spain: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

12.1.2.6 Rest of Europe: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.6.1 Overview

12.1.2.6.2 Rest of Europe: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.6.3 Rest of Europe: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)

12.1.2.6.4 Rest of Europe: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)

12.1.2.6.5 Rest of Europe: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)

12.1.2.6.6 Rest of Europe: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.2.6.7 Rest of Europe: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

13. Europe Influenza Vaccine Market –Industry Landscape

13.1 Overview

13.2 Growth Strategies in the Influenza Vaccine Market, 2021-2028

13.3 Inorganic Growth Strategies

13.3.1 Overview

13.4 Organic Growth Strategies

13.4.1 Overview

14. Company Profiles

14.1 Moderna, Inc.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 SEQIRUS

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Sanofi

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 GlaxoSmithKline plc.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Emergent BioSolutions Inc.

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Mitsubishi Chemical Group Corporation

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Serum Institute of India Pvt. Ltd

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 MYLAN N.V.

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 AstraZeneca

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. Below are a few instances of companies and their pipeline products:

Table 2. Europe Influenza Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Table 3. Europe Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)

Table 4. Europe: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)

Table 5. Europe Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 6. Europe Influenza Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 7. Europe Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 8. Germany Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)

Table 9. Germany: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)

Table 10. Germany Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 11. Germany Influenza Vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 12. Germany Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 13. UK Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)

Table 14. UK: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)

Table 15. UK Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 16. UK Influenza Vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 17. UK Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 18. France Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)

Table 19. France: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)

Table 20. France Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 21. France Influenza Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 22. France Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 23. Italy Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)

Table 24. Italy: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)

Table 25. Italy Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 26. Italy Influenza Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 27. Italy Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 28. Spain Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)

Table 29. Spain: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)

Table 30. Spain Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 31. Spain Influenza Vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 32. Spain Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 33. Rest of Europe Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)

Table 34. Rest of Europe: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)

Table 35. Rest of Europe Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 36. Rest of Europe Influenza Vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 37. Rest of Europe Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 38. Recent Inorganic Growth Strategies in the Influenza Vaccine Market

Table 39. Recent Organic Growth Strategies in the Influenza Vaccine Market

Table 40. Glossary of Terms, Influenza Vaccines Market

LIST OF FIGURES

Figure 1. Europe Influenza Vaccines Market Segmentation

Figure 2. Europe Influenza Vaccines Market Segmentation, by Country

Figure 3. Europe Influenza Vaccines Market Overview

Figure 4. Quadrivalent Vaccines Segment Held Largest Share of Product Segment in Europe Influenza Vaccines Market

Figure 5. UK Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Europe: PEST Analysis

Figure 7. Experts Opinion

Figure 8. Europe Influenza Vaccines Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 9. Europe Influenza Vaccines Market, by Vaccine Type 2022 & 2028 (%)

Figure 10. Quadrivalent Vaccines: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11. Trivalent Vaccines: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. Europe Influenza Vaccines Market, by Virus Type 2022 & 2028 (%)

Figure 13. Influenza Virus Type A : Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. Influenza Virus Type B: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. Europe Influenza Vaccines Market, by Technology 2022 & 2028 (%)

Figure 16. Egg-based: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. Cell-Based: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18. Europe Influenza Vaccines Market, by Route of Administration 2022 & 2028 (%)

Figure 19. Injection: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20. Nasal Spray: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21. Europe Influenza Vaccines Market, by Target Group 2022 & 2028 (%)

Figure 22. Infants : Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23. Children: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24. Adults: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25. Elderly People: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26. Europe: Influenza Vaccines Market, by Key Country – Revenue (2022) (US$ Million)

Figure 27. Europe: Influenza Vaccines Market, by Country, 2022 & 2028 (%)

Figure 28. Germany: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. UK: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. France: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. Italy: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. Spain: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. Rest of Europe: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. Growth Strategies in the Influenza Vaccine Market, 2021-2028